T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fortinet
FTNT
|
+$2.09B |
| 2 |
Rockwell Automation
ROK
|
+$1.46B |
| 3 |
Autodesk
ADSK
|
+$1.19B |
| 4 |
Citigroup
C
|
+$1.11B |
| 5 |
ConocoPhillips
COP
|
+$1.08B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.23B |
| 2 |
GE Aerospace
GE
|
+$2.12B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.46B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.17B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| 1 | Technology | 32.25% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Endava
DAVA
$539M
| $169M | 0.02% |
4,435,144
-3,018,188
| -40% | -$115M |
|
452
Zscaler
ZS
$44B
| $168M | 0.02% |
873,693
-576,452
| -40% | -$111M |
|
453
Aurora
AUR
$10.5B
| $167M | 0.02% |
59,352,847
-471,535
| -0.8% | -$1.33M |
|
454
Lattice Semiconductor
LSCC
$9.05B
| $167M | 0.02% |
2,137,142
-432,169
| -17% | -$33.8M |
|
455
Ultragenyx Pharmaceutical
RARE
$3.04B
| $167M | 0.02% |
3,568,873
+120,175
| +3% | +$5.61M |
|
456
PTC
PTC
$24.4B
| $165M | 0.02% |
875,282
+40,462
| +5% | +$7.64M |
|
457
Packaging Corp of America
PKG
$19.3B
| $165M | 0.02% |
869,341
+42,465
| +5% | +$8.06M |
|
458
Mettler-Toledo International
MTD
$26.5B
| $163M | 0.02% |
122,655
+57,509
| +88% | +$76.6M |
|
459
Jackson Financial
JXN
$6.72B
| $163M | 0.02% |
2,466,990
-629,850
| -20% | -$41.7M |
|
460
International Flavors & Fragrances
IFF
$16.7B
| $163M | 0.02% |
1,895,581
+162,179
| +9% | +$13.9M |
|
461
Main Street Capital
MAIN
$5.9B
| $163M | 0.02% |
3,439,346
+3,838
| +0.1% | +$182K |
|
462
Moody's
MCO
$91.1B
| $162M | 0.02% |
412,331
-3,166
| -0.8% | -$1.24M |
|
463
Republic Services
RSG
$71.5B
| $161M | 0.02% |
842,392
-19,555
| -2% | -$3.74M |
|
464
CDW
CDW
$22.1B
| $159M | 0.02% |
620,190
+195,951
| +46% | +$50.1M |
|
465
Immunocore
IMCR
$1.84B
| $158M | 0.02% |
2,437,584
-506,990
| -17% | -$33M |
|
466
Nutrien
NTR
$27.4B
| $157M | 0.02% |
2,892,488
-5,098,897
| -64% | -$277M |
|
467
Expro
XPRO
$1.4B
| $156M | 0.02% |
7,830,950
-1,570,016
| -17% | -$31.4M |
|
468
Revolution Medicines
RVMD
$7.65B
| $155M | 0.02% |
4,814,310
+177,957
| +4% | +$5.74M |
|
469
Motorola Solutions
MSI
$79.6B
| $155M | 0.02% |
435,843
+95,078
| +28% | +$33.8M |
|
470
Ionis Pharmaceuticals
IONS
$10.3B
| $153M | 0.02% |
3,522,203
-732,871
| -17% | -$31.8M |
|
471
CoStar Group
CSGP
$37.3B
| $151M | 0.02% |
1,567,199
-1,701
| -0.1% | -$164K |
|
472
Strategy Inc Common Stock Class A
MSTR
$93.2B
| $151M | 0.02% |
887,620
+108,350
| +14% | +$18.5M |
|
473
Acadia Realty Trust
AKR
$2.54B
| $151M | 0.02% |
8,848,246
+388,067
| +5% | +$6.6M |
|
474
Idexx Laboratories
IDXX
$52.5B
| $150M | 0.02% |
277,516
+90
| +0% | +$48.6K |
|
475
Extra Space Storage
EXR
$30.8B
| $149M | 0.02% |
1,014,718
-1,765,911
| -64% | -$260M |
|